March 15, 2023 02:51 PM EDTUpdated March 17, 12:59 PM
Pharma
Law

Up­dat­ed: Am­gen sued in fed­er­al court for al­leged­ly hid­ing $10.7B IRS bill from in­vestors

Paul Schloesser

Associate Editor

Al­most a year af­ter Am­gen told in­vestors that the IRS want­ed bil­lions of dol­lars in back tax­es, a De­troit pen­sion fund is tak­ing on Am­gen …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Halozyme with­draws Evotec ac­qui­si­tion pro­pos­al af­ter biotech is 'un­will­ing to en­gage'

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times